News


First test focused on risk assessment of Acute Kidney Injury in pediatric patients.

BioPorto Submits Pediatric Application to FDA for The NGAL T…

May 2019

World Kidney Day 2018

February 2018

An expansion of BioPorto Diagnostics Metabolic Marker Portfolio

Launch of New Oxyntomodulin Antibodies (OXM)

January 2018

1 2 3 4 5 6 7